The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,021
Biomimetic Model of Tumor Microenvironment on Microfluidic Platform
Chung, M., Ahn, J., Son, K., Kim, S., & Jeon, N. L. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700196 · Cited by 126
Vickerman, V., & Kamm, R. D. (2012) · Integrative Biology · doi:10.1039/c2ib00184e · Cited by 126
Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting
Vandekeere, S., Dewerchin, M. A., & Carmeliet, P. (2015) · Microcirculation · doi:10.1111/micc.12229 · Cited by 126
Self-citationWhat Is the Best Preoperative Imaging for Endometrial Cancer?
Haldorsen, I. S., & Salvesen, H. B. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0506-0 · Cited by 126
Cao, H., Wang, L., Yang, Y., Li, J., Qi, Y., Li, Y., Li, Y., Wang, H., & Li, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802497 · Cited by 126
Vascular Normalization: A New Window Opened for Cancer Therapies
Yang, T., Xiao, H., Liu, X., Wang, Z., Zhang, Q., Wei, N., & Guo, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719836 · Cited by 126
MicroRNAs in cancer metastasis and angiogenesis
Lou, W., Liu, J., Gao, Y., Zhong, G., Chen, D., Shen, J., Bao, C., Xu, L., Pan, J., Cheng, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23115 · Cited by 125
A molecular map of murine lymph node blood vascular endothelium at single cell resolution
Brulois, K., Rajaraman, A., Szade, A., Nordling, S., Bogoslowski, A., Đermadi, D., Rahman, M., Kiefel, H., O’Hara, E., Koning, J. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17291-5 · Cited by 125
Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis
Bu, L., Dai, O., Zhou, F., Liu, F., Chen, J., Peng, C. Y., & Xiong, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110855 · Cited by 125
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies
Liu, X., Zhang, J., Yi, T., Li, H., Tang, X., Liu, D., Wu, D., & Li, Y. (2025) · Biomarker Research · doi:10.1186/s40364-025-00779-x · Cited by 125
Hachey, S. J., Movsesyan, S., Nguyen, Q. H., Burton-Sojo, G., Tankazyan, A., Wu, J., Hoang, T., Zhao, D., Wang, S., Hatch, M. M., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc01216e · Cited by 124
Checco, J. W., Kreitler, D. F., Thomas, N. C., Belair, D. G., Rettko, N. J., Murphy, W. L., Forest, K. T., & Gellman, S. H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420380112 · Cited by 124
Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis
Seano, G., Chiaverina, G., Gagliardi, P. A., di Blasio, L., Puliafito, A., Bouvard, C., Sessa, R., Tarone, G., Sorokin, L. M., Helley, D., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3036 · Cited by 124
Self-citationInvestigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases
Jeong, H., Jones, D., Liao, S., Wattson, D. A., Cui, C. H., Duda, D. G., Willett, C. G., Jain, R. K., & Padera, T. P. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv155 · Cited by 124
Self-citationStructure and Functions of Blood Vessels and Vascular Niches in Bone
Ramasamy, S. K. (2017) · Stem Cells International · doi:10.1155/2017/5046953 · Cited by 125
Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis
Chandler, K. B., Costello, C. E., & Rahimi, N. (2019) · Cells · doi:10.3390/cells8060544 · Cited by 124
Angiopoietin inhibitors: A review on targeting tumor angiogenesis
Digna, P., & Apte, M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174021 · Cited by 124
Xiang, J., Li, J., He, J., Tang, X., Dou, C., Cao, Z., Yu, B., Zhao, C., Kang, F., Lü, Y., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00158 · Cited by 123
New Directions in Anti-Angiogenic Therapy for Glioblastoma
Wang, N., Jain, R. K., & Batchelor, T. T. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0510-y · Cited by 123
Self-citationBai, Y., Bai, L., Zhou, J., Chen, H., & Zhang, L. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.008 · Cited by 123
Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma
Nasry, W. H. S., Rodriguez-Lecompte, J. C., & Martin, C. K. (2018) · Cancers · doi:10.3390/cancers10100348 · Cited by 123
Duchesne, C., Banzet, S., Lataillade, J., Rousseau, A., & Frescaline, N. (2019) · The Journal of Pathology · doi:10.1002/path.5323 · Cited by 123
Lin, S., Zhang, Q., Li, S., Zhang, T., Wang, L., Qin, X., Zhang, M., Shi, S., & Cai, X. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c00874 · Cited by 123
The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids
Agudo, J., Ruzo, A., Tung, N., Salmon, H., Leboeuf, M., Hashimoto, D., Becker, C., Garrett-Sinha, L.-A., Baccarini, A., Merad, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2767 · Cited by 122
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
Marques, P., Barry, S., Carlsen, E., Collier, D., Ronaldson, A., Awad, S., Dorward, N., Grieve, J., Mendoza, N., Muquit, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0830-3 · Cited by 122
A perfusable, multifunctional epicardial device improves cardiac function and tissue repair
Huang, S., Lei, D., Yang, Q., Yang, Y., Jiang, C., Shi, H., Qian, B., Long, Q., Chen, W., Chen, Y., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01279-9 · Cited by 122
Ultrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicine
Snipstad, S., Vikedal, K., Maardalen, M., Kurbatskaya, A., Sulheim, E., & Davies, C. D. L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113847 · Cited by 122
Regulation and role of endogenously produced hydrogen sulfide in angiogenesis
Katsouda, A., Bibli, S., Pyriochou, A., Szabó, C., & Papapetropoulos, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.026 · Cited by 121
Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation
Choi, D., Lee, T. H., Spinelli, C., Chennakrishnaiah, S., D’Asti, E., & Rak, J. W. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.01.003 · Cited by 121
Mural lymphatic endothelial cells regulate meningeal angiogenesis in the zebrafish
Bower, N. I., Koltowska, K., Pichol-Thievend, C., Virshup, I., Paterson, S., Lagendijk, A. K., Wang, W., Lindsey, B. W., Bent, S. J., Baek, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4558 · Cited by 121
Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis
Cao, Z., Ye, T., Sun, Y., Ji, G., Shido, K., Chen, Y., Luo, L., Na, F., Li, X., Huang, Z., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8710 · Cited by 121
Bocca, P., Carlo, E. D., Caruana, I., Emionite, L., Cilli, M., Angelis, B. D., Quintarelli, C., Pezzolo, A., Raffaghello, L., Morandi, F., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1378843 · Cited by 121
Zhao, Y., Bai, L., Zhang, Y., Yao, R., Sun, Y., Hang, R., Chen, X., Wang, H., Yao, X., Xiao, Y., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121684 · Cited by 121
Oudega, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1440-6 · Cited by 121
Pathogenesis of herpes stromal keratitis – A focus on corneal neovascularization
Giménez, F., Suryawanshi, A. S., & Rouse, B. T. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.07.002 · Cited by 121
Nogo-A is a negative regulator of CNS angiogenesis
Wälchli, T., Pernet, V., Weinmann, O., Shiu, J.-Y., Guzik-Kornacka, A., Decrey, G., Yüksel, D., Schneider, H., Vogel, J., Ingber, D. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216203110 · Cited by 120
Li, D., He, S., Wu, Y., Liu, J., Liu, Q., Chang, B., Zhang, Q., Xiang, Z., Yuan, Y., Jian, C., et al. (2019) · Advanced Science · doi:10.1002/advs.201902042 · Cited by 120
Tumor Stroma, Tumor Blood Vessels, and Antiangiogenesis Therapy
Dvorak, H. F. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000124 · Cited by 120
Joint pathology and platelet-rich plasma therapies
Andı́a, I., Sánchez, M., & Maffulli, N. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.632765 · Cited by 119
Mast cells: A double-edged sword in cancer
Derakhshani, A., Vahidian, F., Ali‐Hassanzadeh, M., Mokhtarzadeh, A., Nezhad, P. L., & Baradaran, B. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.03.011 · Cited by 119
Jurj, A. M., Zănoagă, O., Braicu, C., Lazar, V., Tomuleasa, C., Irimie, A., & Berindan‐Neagoe, I. (2020) · Cancers · doi:10.3390/cancers12020298 · Cited by 119
Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy
Rey, S., Schito, L., Wouters, B. G., Eliasof, S. D., & Kerbel, R. S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.05.002 · Cited by 118
High mitogenic stimulation arrests angiogenesis
Pontes-Quero, S., Fernández-Chacón, M., Luo, W., Lunella, F. F., Casquero-García, V., García-Gónzalez, I., Hermoso, A., Rocha, S. F., Bansal, M., & Benedito, R. (2019) · Nature Communications · doi:10.1038/s41467-019-09875-7 · Cited by 118
Kim, S., Seong, K.-J., Kim, W.-J., & Jung, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074004 · Cited by 118
Wang, W., Ren, F., Wu, Q., Jiang, D., Li, H., & Huirong, S. (2014) · Oncology Reports · doi:10.3892/or.2014.3439 · Cited by 117
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism
Verdegem, D., Moens, S., Stapor, P. C., & Carmeliet, P. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-19 · Cited by 117
Self-citationNeutrophil Extracellular Traps, Angiogenesis and Cancer
Poto, R., Cristinziano, L., Modestino, L., de Paulis, A., Marone, G., Loffredo, S., Galdiero, M. R., & Varricchi, G. (2022) · Biomedicines · doi:10.3390/biomedicines10020431 · Cited by 120
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
Péqueux, C., Raymond‐Letron, I., Blacher, S., Boudou, F., Adlanmérini, M., Fouque, M.-J., Rochaix, P., Noël, A., Foidart, J.-M., Krust, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3768 · Cited by 117
Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease
Kida, Y., Tchao, B. N., & Yamaguchi, I. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2430-y · Cited by 117
Vascular Endothelial Growth Factor-Delivery Systems for Cardiac Repair: An Overview
Simón‐Yarza, T., Formiga, F. R., Tamayo, E., Pelacho, B., Prósper, F., & Blanco‐Prieto, M. J. (2012) · Theranostics · doi:10.7150/thno.3682 · Cited by 117
Quantification of Microvascular Tortuosity during Tumor Evolution Using Acoustic Angiography
Shelton, S. E., Lee, Y. Z., Lee, M., Chérin, E., Foster, F. S., Aylward, S., & Dayton, P. A. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.02.012 · Cited by 116
Tamura, R., Tanaka, T., Miyake, K., Yoshida, K., & Sasaki, H. (2017) · Brain Tumor Pathology · doi:10.1007/s10014-017-0284-x · Cited by 116
The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis
Gao, P., Niu, N., Wei, T., Tozawa, H., Chen, X., Zhang, W., Zhang, J., Wada, Y., Kapron, C. M., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19932 · Cited by 116
Modelling skin wound healing angiogenesis: A review
Guerra, A., Belinha, J., & Jorge, R. N. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.09.020 · Cited by 116
Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy
Uribesalgo, I., Hoffmann, D., Zhang, Y., Kavirayani, A. M., Lazović, J., Berta, J., Novatchkova, M., Pai, T., Wimmer, R., László, V., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809266 · Cited by 116
Role of miRNAs in tumor and endothelial cell interactions during tumor progression
Orso, F., Quirico, L., Dettori, D., Coppo, R., Virga, F., Ferreira, L. C., Paoletti, C., Baruffaldi, D., Penna, E., & Taverna, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.024 · Cited by 116
Biological aspects in controlling angiogenesis: current progress
Akbarian, M., Bertassoni, L. E., & Tayebi, L. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04348-5 · Cited by 116
Nephrotoxicity of recent anti-cancer agents
Lameire, N. H. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft135 · Cited by 116
Endothelial Cells Are Able to Synthesize and Release Catecholamines Both In Vitro and In Vivo
Sorriento, D., Santulli, G., Giudice, C. D., Anastasio, A., Trimarco, B., & Iaccarino, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189605 · Cited by 116
Wang, F., Sun, W., Zhang, J., & Fan, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.9973 · Cited by 115
Transcriptional regulation of endothelial cell behavior during sprouting angiogenesis
Jeong, H., Hernández-Rodríguez, B., Kim, J., Kim, K.-P., Enriquez-Gasca, R., Yoon, J., Adams, S., Schöler, H. R., Vaquerizas, J. M., & Adams, R. H. (2017) · Nature Communications · doi:10.1038/s41467-017-00738-7 · Cited by 115
Abbaszadeh, H., Keikhaei, B., & Mottaghi, S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6403 · Cited by 115
Therapeutic potential of curcumin in eye diseases
Radomska-Leśniewska, D. M., Osiecka‐Iwan, A., Hyc, A., Góźdź, A., Dąbrowska, A. M., & Skopiński, P. (2019) · Central European Journal of Immunology · doi:10.5114/ceji.2019.87070 · Cited by 115
Kudo, M., Ueshima, K., Saeki, I., Ishikawa, T., Inaba, Y., Morimoto, N., Aikata, H., Tanabe, N., Wada, Y., Kondo, Y., et al. (2023) · Liver Cancer · doi:10.1159/000531377 · Cited by 115
Rowe, G. C., Raghuram, S., Jang, C., Nagy, J. A., Patten, I. S., Goyal, A., Chan, M. C., Liu, L. X., Jiang, A., Spokes, K., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303829 · Cited by 115
MicroRNAs as pharmacological targets in endothelial cell function and dysfunction
Chamorro-Jorganes, A., Araldi, E., & Suárez, Y. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.002 · Cited by 115
Large-scale time series microscopy of neovessel growth during angiogenesis
Utzinger, U., Baggett, B. K., Weiss, J. A., Hoying, J. B., & Edgar, L. T. (2015) · Angiogenesis · doi:10.1007/s10456-015-9461-x · Cited by 114
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma
Nowosielski, M., Wiestler, B., Goebel, G., Hutterer, M., Schlemmer, H. P., Stockhammer, G., Wick, W., Bendszus, M., & Radbruch, A. (2014) · Neurology · doi:10.1212/wnl.0000000000000402 · Cited by 114
Wang, J., Li, G., Wang, Y., Tang, S., Sun, X., Feng, X., Li, Y., Bao, G., Li, P., Mao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6373 · Cited by 114
Chemoprevention of Breast Cancer by Dietary Polyphenols
Mocanu, M., Nagy, P., & Szöllõsi, J. (2015) · Molecules · doi:10.3390/molecules201219864 · Cited by 114
Alsaif, N. A., Dahab, M. A., Alanazi, M. M., Obaidullah, A. J., Almehizia, A. A., Alanazi, M. M., Aldawas, S., Mahdy, H. A., & Elkady, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104807 · Cited by 114
Macrophage regulation of angiogenesis in health and disease
Martin, P. B., & Gurevich, D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.010 · Cited by 114
Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway
Mammoto, T., Jiang, A. R., Jiang, E., & Mammoto, A. (2013) · Microvascular Research · doi:10.1016/j.mvr.2013.04.008 · Cited by 114
Iaconetti, C., Polimeni, A., Sorrentino, S., Sabatino, J., Pironti, G., Esposito, G., Curcio, A., & Indolfi, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0296-y · Cited by 113
Cao, Z., Yu, D., Fu, S., Zhang, G., Pan, Y., Bao, M., Tu, J., Shang, B., Guo, P.-D., Yang, P., et al. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.01.018 · Cited by 113
Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2
Dwyer, J., Hebda, J. K., Guelte, A. L., Galán‐Moya, E. M., Smith, S. S., Azzi, S., Bidère, N., & Gavard, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045562 · Cited by 113
Signaling Pathways in the Specification of Arteries and Veins
Corada, M., Morini, M. F., & Dejana, E. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303218 · Cited by 113
Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip
Lee, H. N., Choi, Y. Y., Kim, J. W., Lee, Y. S., Choi, J. W., Kang, T., Kim, Y. K., & Chung, B. G. (2021) · Nano Convergence · doi:10.1186/s40580-021-00285-4 · Cited by 113
The vasohibin family: a novel family for angiogenesis regulation
Sato, Y. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs128 · Cited by 113
Day, D. S., Day, D. S., Ho, J. W., Song, L., Cao, J., Christodoulou, D., Seidman, J. G., Crawford, G. E., Park, P. J., & Pu, W. T. (2013) · Genome Research · doi:10.1101/gr.149674.112 · Cited by 113
Hijnen, N. M., Langereis, S., & Grüll, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.006 · Cited by 112
Liu, N., Ding, D., Hao, W., Yang, F., Wu, X., Wang, M., Xu, X., Ju, Z., Liu, J., Song, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw549 · Cited by 112
Valdor, R., García‐Bernal, D., Riquelme, D., Martínez, C. M., Moraleda, J. M., Cuervo, A. M., Macián, F., & Martı́nez, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903542116 · Cited by 112
Yang, K., Li, D., Wang, M., Xu, Z., Chen, X., Liu, Q., Sun, W., Li, J., Gong, Y., Liu, D., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1472-x · Cited by 112
Advancements in Hydrogel-Based Drug Sustained Release Systems for Bone Tissue Engineering
Zhang, Y., Yu, T., Peng, L., Sun, Q., Wei, Y. Q., & Han, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00622 · Cited by 112
Fu, J., Yu, M. G., Li, Q., Park, K., & King, G. L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101236 · Cited by 112
Neurotrophins and their receptors in breast cancer
Hondermarck, H. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.06.004 · Cited by 112
Boettger, T., & Braun, T. W. (2012) · Circulation Research · doi:10.1161/circresaha.111.247742 · Cited by 111
How Endothelial Cells Adapt Their Metabolism to Form Vessels in Tumors
Zecchin, A., Kalucka, J. M., Dubois, C., & Carmeliet, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01750 · Cited by 111
Self-citationStructure and function of vascular endothelial growth factor and its receptor system
Park, S. A., Jeong, M. S., Ha, K., & Jang, S. B. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.2.233 · Cited by 111
Alternative Splicing in Angiogenesis
Bowler, E., & Oltean, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092067 · Cited by 111
Wu, V., Helder, M. N., Bravenboer, N., Bruggenkate, C. M. T., Jin, J., Klein‐Nulend, J., & Schulten, E. A. J. M. (2019) · Stem Cells International · doi:10.1155/2019/6279721 · Cited by 111
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 111
Viral oncogenesis in cancer: from mechanisms to therapeutics
Xiao, Q., Liu, Y., Li, T., Wang, C., He, S., Zhai, L., Yang, Z., Zhang, X., Wu, Y., & Liu, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02197-9 · Cited by 111
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling
Pasula, S., Cai, X., Dong, Y., Messa, M., McManus, J., Chang, B., Liu, X., Zhu, H., Silasi‐Mansat, R., Yoon, S.-J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64537 · Cited by 111
Dietary nitrate supplementation improves revascularization in chronic ischemia
Hendgen-Cotta, U. B., Luedike, P., Totzeck, M., Kropp, M., Schicho, A., Stock, P., Rammos, C., Niessen, M., Heiss, C., Lundberg, J. O., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.112912 · Cited by 110
Gutbrodt, K. L., Schliemann, C., Giovannoni, L., Frey, K., Pabst, T., Klapper, W., Berdel, W. E., & Neri, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006221 · Cited by 110
Li, T., Shen, X., Geng, Y., Chen, Z., Li, L., Li, S., Yang, H., Wu, C., Zeng, H., & Liu, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02963 · Cited by 110
Asymmetric division coordinates collective cell migration in angiogenesis
Costa, G., Harrington, K., Lovegrove, H. E., Page, D. J., Chakravartula, S., Bentley, K., & Herbert, S. P. (2016) · Nature Cell Biology · doi:10.1038/ncb3443 · Cited by 110
Duan, M., Zhou, H., Wu, Q., Liu, C., Xiao, Y., Deng, W., & Tang, Q. (2019) · Mediators of Inflammation · doi:10.1155/2019/6168340 · Cited by 110
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
